Quarterly Summary—Recent Developments in VHL-Related Research

Commentary · July 03, 2019

Belzutifan in VHL Syndrome

Cases · March 23, 2022

  1 Comments

Papillomacular Bundle Hemangioblastoma in a 19-Year-Old Woman With VHL

Cases · October 14, 2019

Planning Forward—Young Man, Newly Diagnosed With Full-blown VHL and His Younger Relatives Awaiting Surveillance Planning—How Would You Proceed?

Cases · July 30, 2019

  3 Comments

Clinical Manifestations of Heterozygote Carrier With Rare VHL Gene Variant Responsible for Congenital Erythrocytosis

Cases · November 19, 2018

  2 Comments

VHL Patient With Pancreatic Lesions

Cases · September 20, 2018

  2 Comments

Clinical Characteristics Associated With Hereditary vs Sporadic Pheochromocytomas

Kaohsiung J Med Sci · July 08, 2024

Prognostic Factors Associated With VHL-Related Pancreatic Neuroendocrine Tumors

J. Clin. Endocrinol. Metab. · July 08, 2024

Centralization of Care for Rare Genetic Syndromes Associated With Cancer: Improving Outcomes and Advancing Research on VHL Disease

Nat Rev Urol · July 05, 2024

Pheochromocytoma in Patients With von Hippel–Lindau Syndrome

J Kidney Cancer VHL · April 16, 2024

Selective HIF2A Inhibitors in the Management of Clear Cell Renal Cancer and von Hippel–Lindau Disease–Associated Tumors

Med Sci (Basel) · October 06, 2023

Hereditary Pheochromocytoma With the von Hippel–Lindau Gene Mutation in a Child

Asian J Surg · May 17, 2023

Belzutifan for the Treatment of von Hippel–Lindau Disease: Changes in Management and Future Challenges

Neuro-oncology · April 17, 2023

The Effect of a Cortical-Sparing Technique on Pheochromocytoma Recurrence in Hereditary Disease

Surgery · February 27, 2023

Immunological Aspects of von Hippel–Lindau Disease: Overlap With Myasthenia Gravis

Diagnostics (Basel) · February 16, 2023

Exploring the Genetic Landscape of Pheochromocytomas and Paragangliomas

J. Clin. Endocrinol. Metab. · March 01, 2022